Related references
Note: Only part of the references are listed.mir-17-92: a polycistronic oncomir with pleiotropic functions
Virginie Olive et al.
IMMUNOLOGICAL REVIEWS (2013)
Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy
Adam J. Litterman et al.
JOURNAL OF IMMUNOLOGY (2013)
Myeloablative Temozolomide Enhances CD8+ T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice
Luis A. Sanchez-Perez et al.
PLOS ONE (2013)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor-Modified T Cells
Seogkyoung Kong et al.
CLINICAL CANCER RESEARCH (2012)
Glioblastoma Stem-like Cell Lines with Either Maintenance or Loss of High-Level EGFR Amplification, Generated via Modulation of Ligand Concentration
Alexander Schulte et al.
CLINICAL CANCER RESEARCH (2012)
The Spectrum of Vaccine Therapies for Patients With Glioblastoma Multiforme
Laura K. Aguilar et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
Richard A. Morgan et al.
HUMAN GENE THERAPY (2012)
Clinical Trials with Immunotherapy for High-Grade Glioma
Jacob Ruzevick et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation
Tuoqi Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MicroRNAs and STAT interplay
Gary Kohanbash et al.
SEMINARS IN CANCER BIOLOGY (2012)
Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation
Shan Jiang et al.
BLOOD (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets
Bruno Salaun et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Glucocorticoid-Mediated Repression of the Oncogenic microRNA Cluster miR-17∼92 Contributes to the Induction of Bim and Initiation of Apoptosis
Jason K. Molitoris et al.
MOLECULAR ENDOCRINOLOGY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners
Xinmei Zhu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Yangbing Zhao et al.
CANCER RESEARCH (2010)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Tumorigenicity of the miR-17-92 cluster distilled
Gijs van Haaften et al.
GENES & DEVELOPMENT (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
Kotaro Sasaki et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence
Akitake Mukasa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells-Significant Roles of CXCL10
Mitsugu Fujita et al.
CANCER RESEARCH (2009)
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Carmine Carpenito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1
Ryo Ueda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
Changchun Xiao et al.
NATURE IMMUNOLOGY (2008)
Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors
Kotaro Sasaki et al.
CANCER RESEARCH (2007)
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
Xinmei Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: Critical roles of IFN-inducible protein-10
F Nishimura et al.
CANCER RESEARCH (2006)
Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors
A Facoetti et al.
CLINICAL CANCER RESEARCH (2005)
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
MA Pulè et al.
MOLECULAR THERAPY (2005)
The natural history of EGFR and EGFRvIII in glioblastoma patients
AB Heimberger et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients
AB Heimberger et al.
CLINICAL CANCER RESEARCH (2005)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells
KS Kahlon et al.
CANCER RESEARCH (2004)
A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells
M Moeller et al.
CANCER GENE THERAPY (2004)
Production of a single-chain variable fragment antibody recognizing type III mutant epidermal growth factor receptor
N Nakayashiki et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2000)
Share Paper
